v3.26.1
Unaudited Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss) for the period $ (160,788) $ (107,780) $ 105,977 $ 78,631 $ (8,519)
Net loss (income) from discontinued operations (158) (4,159) 400 2,030 (1,141)
Net income (loss) for the period from continuing operation (160,630) (111,939) 106,377 76,601 (7,378)
Adjustments required to reconcile net loss for the period to net cash used in operating activities:          
Amortization of debt discount 414     0 316
Amortization and Depreciation 0 438 323 4 0
Stock-based compensation 6 1,907 178 18,826 230
Interest earned on marketable securities held in Trust Account   (3,110) 0 (278)  
Loss on extinguishment of vendor obligations 278     0 289
Gain on extinguishment of vendor obligations 0     0 (211)
Gain on extinguishment of affiliates liabilities due to 0     0 (192)
Impairment loss 0     4,344 391
Gain on deconsolidation (64)     0 0
Loss on extinguishment of convertible notes payable 0     7,080 0
Shares and warrants issued in connection with JV agreement 0     2,817 0
Shares issued as part of settlement agreement 0     157 0
Shares issued as penalty for filing 0     300 0
Shares issued as commitment for ELOC agreement 0     1,250 0
Employee extermination   (14) 0    
Deferred taxes   (162) 0    
Interest on loans   (151) 0    
Gain on sale of subsidiary   (1,744) 0    
Loss on marketable securities 0 3,705 0 (301) 0
Day one loss on stock purchase warrants issued in connection with private placement 13,533     13,435 0
Change in fair value – convertible note embedded derivative   (234) (588)    
Change in fair value - stock purchase warrant liabilities 663 102,231 (109,406) (130,135) 0
Change in fair value of liability-classified stock purchase warrants 140,585     (588) 0
Changes in lease assets and lease liabilities 0 (38) 0 (151)  
Change in fair value of derivative liabilities 625     0 0
Loss on reclassification of stock purchase warrants from equity-classified to liability-classified 46     0 0
Changes in operating assets and liabilities:          
Trade receivables   (255) 0    
Other current assets 136 (153) (444) (264) (236)
Due from related parties   0 (132)    
Inventory   (916) 0    
Accounts payable 70 597 28 30 0
Due to affiliates 0 0 87 0 2,919
Interest payable - related parties 21 629 51 (34) 44
Accrued expenses and other current liabilities 2,861 (686) 545 760 2,935
Net cash used in operating activities – continuing operations (1,456) (9,895) (2,981) (6,147) (893)
Net cash used in operating activities – discontinuing operations 1,116 104 287 (51) (2,925)
Net cash used in operating activities (340) (9,791) (2,694) (6,198) (3,818)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash used in purchase of subsidiaries   (4,476) 0    
Short term deposit   (52) 0    
Deconsolidation of subsidiary   (1,112) 0    
Proceeds from sales short term securities   239 0    
Proceeds from sale of investment 64     0 0
Investment in short term securities 0     50 0
Loan granted 0     (2,351) 0
Investment of cash in Trust Account       (172,500)  
Due to affiliates, net 0     (984) 0
Cash provided by purchase of subsidiaries 0 1,138 0 449 0
Payment on property and equipment 0 (180) (15) (31) 0
Advance to target of planned acquisition (1,000) 0 (1,500) (3,500) 0
Net cash used in investing activities – continuing operations (936)     (178,867) 0
Net cash used in investing activities – discontinuing operations 0     (960) 133
Net cash used in investing activities (936) (4,443) (1,515) (179,827) 133
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayment on short term bank credit   (455) 0    
Repayment of note payable   (2,543) (78)    
Payments of penalty – late registration     (800)    
Business Combination, net of issuance costs 0     0 150
Proceeds from loans payable - related parties 0 535 0 0 1,354
Proceeds from issuance of private placement and embedded derivative, net of issuance costs 9,135     9,225 0
Proceeds from sale of SPAC Units and Private Placement Units, net of issuance costs 0     172,854 0
Proceeds from issuance of common stock, net of issuance costs 478     172,500 0
Repayments on loans payable - related parties (1,000)     (94) 0
Proceeds from issuance of convertible notes payable and embedded derivative, net of issuance costs 450     0 0
Proceeds from issuance of convertible notes payable and stock purchase warrants, net of issuance costs 0     5,382 996
Proceeds from issuance of note payable and stock purchase warrants 0     0 78
Repayments of loans   (409) 0    
Payment of liability to former shareholder of a subsidiary   (288) 0    
Company's portion in investment of minority in subsidiary   440 0    
Proceeds from issuance of ELOC   8,073 0    
Proceeds from issuance of private placement, net   10,000 0    
Net cash provided by financing activities – continuing operations 9,063     181,985 2,578
Net cash provided by financing activities – discontinuing operations 0     0 422
Net cash provided by (used in) financing activities 9,063 15,353 (878) 181,985 3,000
Effect of exchange rate changes on cash and cash equivalents – continuing operations 36 0 (4) 95 29
Effect of exchange rate changes on cash and cash equivalents – discontinuing operations 0 0 107 34 0
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 7,823 1,119 (4,984) (3,911) (656)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD, INCLUDING DISCONTINUED OPERATIONS 35 3,947 7,858 7,858  
CASH, CASH EQUIVALENTS, RESTRICTED CASH INCLUDING CASH FROM HELD FOR SELL COMPANY AT END OF PERIOD, INCLUDING DISCONTINUED OPERATIONS 7,858 5,066 2,874 3,947 35
LESS CASH FROM DISCONTINUED OPERATIONS 960 0 1,354 0 35
CASH, CASH EQUIVALENTS, RESTRICTED CASH INCLUDING CASH FROM DISCONTINUED OPERATIONS AT END OF PERIOD FROM CONTINUING OPERATIONS 6,898 5,066 1,520 3,947 0
Supplemental disclosure of cash flow information:          
Cash paid for: Interest 0 0 6 0 1
Non-cash transactions:          
Investment in investee   2,354      
Fair value of pre-funded warrants exercised   0 3,056    
Fair value of the derivative liability extinguished from conversion of convertible note   0 260 260 0
Fair value of warrants exercised 0     31,919 0
Share issued to cover subsidiary's liabilities 0     509 0
Offering costs included in accrued offering costs 0     76 0
Fair value of common stock issued in connection with settlement agreement   0 158    
Fair value of common stock issued in connection with conversion of convertible note 0 0 521 1,532 0
Cash provided by purchase of subsidiary consolidated for the first time:          
Deferred considerations       (14,103)  
Exercise of Warrants   17,758 0    
Issuance of common stock to settle loans payable – related parties and accrued and unpaid interest 0     0 613
Capital reduction on settlement of loans payable – related parties and accrued and unpaid interest through issuance of common stock 0     0 (343)
Issuance of common stock to settle due to affiliates 0     0 6,627
Capital reduction on settlement of due to affiliates through issuance of common stock 0     0 (3,900)
Settlement of due to affiliates through issuance of loan payable – related parties 0     0 1,213
Settlement of accrued expenses and other current liabilities through issuance of Old Nukk common stock 0     0 213
Issuance of Old Nukk common stock to Brilliant vendors in exchange for receivable from Brilliant 0     0 1,802
Settlement of loans payable – related parties through exchange of notes receivable – related parties and accrued and unpaid interest 0     0 38
Settlement of loans payable – related parties through exchange of due from affiliates 0       12
Fair value of the stock purchase warrants issued in connection with the private placement agreement 23,239     0 0
Issuance of common stock issued as compensation for services 1,364     0 0
Issuance of common stock issued to settle Exit and Settlement Agreement 325     0 0
Issuance of common stock issued as compensation to board of directors 959     0 0
Fair value of derivative liability embedded within convertible note payable (848)     0 0
Fair value of liability-classified warrants issued in connection with conversion of convertible notes (663)        
Settlement of convertible notes payable through issuance of common stock 771        
Fair value of stock purchase warrants reclassified from equity-classified to liability-classified (283)        
Issuance of common stock for digital assets purchased 0     4,360 0
Initial recognition of operating lease liability and a corresponding right-of- use asset 0 31 0 695 0
Conversion of promissory note   2,439 0    
Conversion of note receivable into shares of Nimbus   3,153 0    
Working capital (excluding cash and cash equivalents)   (16,028)   (858)  
Long terms assets   7,723   323  
Intangible assets   5,182   7,388  
Goodwill   91,358   7,688  
Intangible assets held for sale   905      
Long terms liabilities   (19,233)   (887)  
Other   139      
Non-controlling interest   (635)      
Issuance of common stock and warrants   (70,549)      
Net cash provided by the purchase of subsidiaries consolidated for the first time   (1,138)   (449)  
Subsidiaries Deconsolidation:          
Working capital (excluding cash and cash equivalents)   120      
Investment in investee   (452)      
Tangible assets   1      
loan from the Company   1,327      
Non-controlling interest   116      
Net cash derived from deconsolidation of subsidiary   $ 1,112      
Previously Reported [Member]          
CASH FLOWS FROM FINANCING ACTIVITIES:          
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD, INCLUDING DISCONTINUED OPERATIONS 35   $ 7,858 7,858 691
CASH, CASH EQUIVALENTS, RESTRICTED CASH INCLUDING CASH FROM HELD FOR SELL COMPANY AT END OF PERIOD, INCLUDING DISCONTINUED OPERATIONS 7,858       35
Cash provided by purchase of subsidiary consolidated for the first time:          
Issuance of common stock to settle accrued expenses and other current liabilities $ 760     $ 0 $ 1,880